{"id":47769,"date":"2022-08-29T19:01:49","date_gmt":"2022-08-29T17:01:49","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/europe-ophthalmic-drug-delivery-system-market-to-grow-at-6-4-through-2031-researchandmarkets-com\/"},"modified":"2022-08-29T19:01:49","modified_gmt":"2022-08-29T17:01:49","slug":"europe-ophthalmic-drug-delivery-system-market-to-grow-at-6-4-through-2031-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/europe-ophthalmic-drug-delivery-system-market-to-grow-at-6-4-through-2031-researchandmarkets-com\/","title":{"rendered":"Europe Ophthalmic Drug Delivery System Market to Grow at 6.4% Through 2031 &#8211; ResearchAndMarkets.com"},"content":{"rendered":"<div>\n<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5624807\/europe-ophthalmic-drug-delivery-system-market?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=rpk3tk&amp;utm_campaign=1743295+-+Europe+Ophthalmic+Drug+Delivery+System+Market+to+Grow+at+6.4%25+Through+2031&amp;utm_exec=como322prd\" rel=\"nofollow noopener\" shape=\"rect\">&#8220;Europe Ophthalmic Drug Delivery System Market 2021-2031 by Product, Dosage Form, Disease, Setting, and Country: Trend Forecast and Growth Opportunity&#8221;<\/a> report has been added to <strong>ResearchAndMarkets.com&#8217;s<\/strong> offering.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20220829005595\/en\/1555663\/4\/logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20220829005595\/en\/1555663\/21\/logo.jpg\"><\/a><\/p>\n<p>\nEurope ophthalmic drug delivery system market was valued at $3,856.3 million in 2021 and will grow by 6.4% annually over 2021-2031, driven by the growing prevalence of ophthalmic diseases, the emerging novel ocular drug delivery systems, rise in number of ophthalmic procedures that require attentive post procedural care, and the increasing demand to deliver controlled dosage forms for pediatric and geriatric population.\n<\/p>\n<p>\n<strong>In-depth qualitative analyses include identification and investigation of the following aspects:<\/strong>\n<\/p>\n<ul>\n<li>\nMarket Structure\n<\/li>\n<li>\nGrowth Drivers\n<\/li>\n<li>\nRestraints and Challenges\n<\/li>\n<li>\nEmerging Product Trends &amp; Market Opportunities\n<\/li>\n<li>\nPorter&#8217;s Fiver Forces\n<\/li>\n<\/ul>\n<p>\n<strong>Based on Product, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.<\/strong>\n<\/p>\n<ul>\n<li>\nPre-filled Syringes\n<\/li>\n<li>\nMultidose Eyedroppers\n<\/li>\n<li>\nSqueeze Dispensers\n<\/li>\n<li>\nMist Sprayers\n<\/li>\n<li>\nContact Lenses\n<\/li>\n<li>\nOcular Inserts\n<\/li>\n<li>\nIntraocular Implants\n<\/li>\n<li>\nPunctal Plugs\n<\/li>\n<li>\nOther Products\n<\/li>\n<\/ul>\n<p>\n<strong>Based on Dosage Form, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.<\/strong>\n<\/p>\n<ul>\n<li>\nSolutions\n<\/li>\n<li>\nGels\n<\/li>\n<li>\nOintments\n<\/li>\n<li>\nSuspensions\n<\/li>\n<li>\nEmulsions\n<\/li>\n<li>\nLiposomes &amp; Nanoparticles\n<\/li>\n<\/ul>\n<p>\n<strong>By Disease, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.<\/strong>\n<\/p>\n<ul>\n<li>\nGlaucoma\n<\/li>\n<li>\nDiabetic Retinopathy\n<\/li>\n<li>\nCataract\n<\/li>\n<li>\nDry Eye Syndrome\n<\/li>\n<li>\nMacular Degeneration\n<\/li>\n<li>\nDiabetic Macular Edema\n<\/li>\n<li>\nRefractive Issues\n<\/li>\n<li>\nOther Diseases\n<\/li>\n<\/ul>\n<p>\n<strong>By Setting, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.<\/strong>\n<\/p>\n<ul>\n<li>\nHospitals\n<\/li>\n<li>\nClinics\n<\/li>\n<li>\nHomecare Settings\n<\/li>\n<li>\nAmbulatory Surgical Centers (ASCs)\n<\/li>\n<li>\nOther Settings\n<\/li>\n<\/ul>\n<p>\n<strong>Geographically, the following national\/local markets are fully investigated:<\/strong>\n<\/p>\n<ul>\n<li>\nGermany\n<\/li>\n<li>\nUK\n<\/li>\n<li>\nFrance\n<\/li>\n<li>\nSpain\n<\/li>\n<li>\nItaly\n<\/li>\n<li>\nNetherlands\n<\/li>\n<li>\nRest of Europe (further segmented into Russia, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)\n<\/li>\n<\/ul>\n<p>\n<strong>Selected Key Players<\/strong>\n<\/p>\n<ul>\n<li>\nAero Pump GmbH\n<\/li>\n<li>\nAllergan plc.\n<\/li>\n<li>\nAptarGroup, Inc.\n<\/li>\n<li>\nBecton, Dickinson and Company\n<\/li>\n<li>\nBiocorp\n<\/li>\n<li>\nClearside Biomedical, Inc.\n<\/li>\n<li>\nEyePoint Pharmaceuticals, Inc.\n<\/li>\n<li>\nGaplast GmbH\n<\/li>\n<li>\nGerresheimer AG\n<\/li>\n<li>\nJotteq Inc.\n<\/li>\n<li>\nKedalion Therapeutics, Inc.\n<\/li>\n<li>\nMati Therapeutics, Inc.\n<\/li>\n<li>\nNemera\n<\/li>\n<li>\nNipro Corporation\n<\/li>\n<li>\nOcular Therapeutix, Inc.\n<\/li>\n<li>\nOcumedic, Inc.\n<\/li>\n<li>\nOwen Mumford\n<\/li>\n<li>\nRe-Vana Therapeutics\n<\/li>\n<li>\nSilgan Holdings Inc.\n<\/li>\n<li>\nTerumo Corporation\n<\/li>\n<li>\nValeant Pharmaceuticals International Inc. (Bausch Health Company)\n<\/li>\n<li>\nWest Pharmaceutical Services, Inc.\n<\/li>\n<\/ul>\n<p>\n<strong>Key Topics Covered:<\/strong>\n<\/p>\n<p>\n<strong>1 Introduction<\/strong>\n<\/p>\n<p>\n<strong>2 Market Overview and Dynamics<\/strong>\n<\/p>\n<p>\n<strong>3 Segmentation of Europe Market by Product<\/strong>\n<\/p>\n<p>\n<strong>4 Segmentation of Europe Market by Dosage Form<\/strong>\n<\/p>\n<p>\n<strong>5 Segmentation of Europe Market by Disease<\/strong>\n<\/p>\n<p>\n<strong>6 Segmentation of Europe Market by Setting<\/strong>\n<\/p>\n<p>\n<strong>7 European Market 2021-2031 by Country<\/strong>\n<\/p>\n<p>\n<strong>8 Competitive Landscape<\/strong>\n<\/p>\n<p>\n<strong>Companies Mentioned<\/strong>\n<\/p>\n<ul>\n<li>\nAero Pump GmbH\n<\/li>\n<li>\nAllergan plc.\n<\/li>\n<li>\nAptarGroup, Inc.\n<\/li>\n<li>\nBecton, Dickinson and Company\n<\/li>\n<li>\nBiocorp\n<\/li>\n<li>\nClearside Biomedical, Inc.\n<\/li>\n<li>\nEyePoint Pharmaceuticals, Inc.\n<\/li>\n<li>\nGaplast GmbH\n<\/li>\n<li>\nGerresheimer AG\n<\/li>\n<li>\nJotteq Inc.\n<\/li>\n<li>\nKedalion Therapeutics, Inc.\n<\/li>\n<li>\nMati Therapeutics, Inc.\n<\/li>\n<li>\nNemera\n<\/li>\n<li>\nNipro Corporation\n<\/li>\n<li>\nOcular Therapeutix, Inc.\n<\/li>\n<li>\nOcumedic, Inc.\n<\/li>\n<li>\nOwen Mumford\n<\/li>\n<li>\nRe-Vana Therapeutics\n<\/li>\n<li>\nSilgan Holdings Inc.\n<\/li>\n<li>\nTerumo Corporation\n<\/li>\n<li>\nValeant Pharmaceuticals International Inc. (Bausch Health Company)\n<\/li>\n<li>\nWest Pharmaceutical Services, Inc.\n<\/li>\n<\/ul>\n<p>\nFor more information about this report visit <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5624807\/europe-ophthalmic-drug-delivery-system-market?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=rpk3tk&amp;utm_campaign=1743295+-+Europe+Ophthalmic+Drug+Delivery+System+Market+to+Grow+at+6.4%25+Through+2031&amp;utm_exec=como322prd\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.researchandmarkets.com\/r\/gaagf0<\/a>\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nResearchAndMarkets.com<br \/>\n<br \/>Laura Wood, Senior Press Manager<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;&#x61;&#x69;&#x6c;&#x74;&#x6f;&#x3a;&#x70;&#x72;&#x65;&#x73;&#x73;&#x40;&#x72;&#x65;&#x73;&#x65;&#x61;&#x72;&#x63;&#x68;&#x61;&#110;&#100;&#109;&#97;&#114;&#107;&#101;&#116;&#115;&#46;&#99;&#111;&#109;\" rel=\"nofollow noopener\" shape=\"rect\">&#112;&#x72;e&#x73;s&#64;&#x72;&#101;&#x73;e&#97;&#x72;&#99;&#x68;a&#x6e;&#x64;&#109;&#x61;r&#x6b;e&#116;&#x73;&#46;&#x63;o&#109;<\/a>\n<\/p>\n<p>\nFor E.S.T Office Hours Call 1-917-300-0470<br \/>\n<br \/>For U.S.\/CAN Toll Free Call 1-800-526-8630<br \/>\n<br \/>For GMT Office Hours Call +353-1-416-8900\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Europe Ophthalmic Drug Delivery System Market 2021-2031 by Product, Dosage Form, Disease, Setting, and Country: Trend Forecast and Growth Opportunity&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. Europe ophthalmic drug delivery system market was valued at $3,856.3 million in 2021 and will grow by 6.4% annually over 2021-2031, driven by the growing prevalence &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/europe-ophthalmic-drug-delivery-system-market-to-grow-at-6-4-through-2031-researchandmarkets-com\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-47769","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Europe Ophthalmic Drug Delivery System Market to Grow at 6.4% Through 2031 - ResearchAndMarkets.com - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/europe-ophthalmic-drug-delivery-system-market-to-grow-at-6-4-through-2031-researchandmarkets-com\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Europe Ophthalmic Drug Delivery System Market to Grow at 6.4% Through 2031 - ResearchAndMarkets.com - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Europe Ophthalmic Drug Delivery System Market 2021-2031 by Product, Dosage Form, Disease, Setting, and Country: Trend Forecast and Growth Opportunity&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. Europe ophthalmic drug delivery system market was valued at $3,856.3 million in 2021 and will grow by 6.4% annually over 2021-2031, driven by the growing prevalence ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/europe-ophthalmic-drug-delivery-system-market-to-grow-at-6-4-through-2031-researchandmarkets-com\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-08-29T17:01:49+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220829005595\/en\/1555663\/21\/logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/europe-ophthalmic-drug-delivery-system-market-to-grow-at-6-4-through-2031-researchandmarkets-com\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/europe-ophthalmic-drug-delivery-system-market-to-grow-at-6-4-through-2031-researchandmarkets-com\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Europe Ophthalmic Drug Delivery System Market to Grow at 6.4% Through 2031 &#8211; ResearchAndMarkets.com\",\"datePublished\":\"2022-08-29T17:01:49+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/europe-ophthalmic-drug-delivery-system-market-to-grow-at-6-4-through-2031-researchandmarkets-com\\\/\"},\"wordCount\":517,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/europe-ophthalmic-drug-delivery-system-market-to-grow-at-6-4-through-2031-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220829005595\\\/en\\\/1555663\\\/21\\\/logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/europe-ophthalmic-drug-delivery-system-market-to-grow-at-6-4-through-2031-researchandmarkets-com\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/europe-ophthalmic-drug-delivery-system-market-to-grow-at-6-4-through-2031-researchandmarkets-com\\\/\",\"name\":\"Europe Ophthalmic Drug Delivery System Market to Grow at 6.4% Through 2031 - ResearchAndMarkets.com - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/europe-ophthalmic-drug-delivery-system-market-to-grow-at-6-4-through-2031-researchandmarkets-com\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/europe-ophthalmic-drug-delivery-system-market-to-grow-at-6-4-through-2031-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220829005595\\\/en\\\/1555663\\\/21\\\/logo.jpg\",\"datePublished\":\"2022-08-29T17:01:49+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/europe-ophthalmic-drug-delivery-system-market-to-grow-at-6-4-through-2031-researchandmarkets-com\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/europe-ophthalmic-drug-delivery-system-market-to-grow-at-6-4-through-2031-researchandmarkets-com\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/europe-ophthalmic-drug-delivery-system-market-to-grow-at-6-4-through-2031-researchandmarkets-com\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220829005595\\\/en\\\/1555663\\\/21\\\/logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220829005595\\\/en\\\/1555663\\\/21\\\/logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/europe-ophthalmic-drug-delivery-system-market-to-grow-at-6-4-through-2031-researchandmarkets-com\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Europe Ophthalmic Drug Delivery System Market to Grow at 6.4% Through 2031 &#8211; ResearchAndMarkets.com\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Europe Ophthalmic Drug Delivery System Market to Grow at 6.4% Through 2031 - ResearchAndMarkets.com - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/europe-ophthalmic-drug-delivery-system-market-to-grow-at-6-4-through-2031-researchandmarkets-com\/","og_locale":"en_US","og_type":"article","og_title":"Europe Ophthalmic Drug Delivery System Market to Grow at 6.4% Through 2031 - ResearchAndMarkets.com - Pharma Trend","og_description":"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Europe Ophthalmic Drug Delivery System Market 2021-2031 by Product, Dosage Form, Disease, Setting, and Country: Trend Forecast and Growth Opportunity&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. Europe ophthalmic drug delivery system market was valued at $3,856.3 million in 2021 and will grow by 6.4% annually over 2021-2031, driven by the growing prevalence ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/europe-ophthalmic-drug-delivery-system-market-to-grow-at-6-4-through-2031-researchandmarkets-com\/","og_site_name":"Pharma Trend","article_published_time":"2022-08-29T17:01:49+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220829005595\/en\/1555663\/21\/logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/europe-ophthalmic-drug-delivery-system-market-to-grow-at-6-4-through-2031-researchandmarkets-com\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/europe-ophthalmic-drug-delivery-system-market-to-grow-at-6-4-through-2031-researchandmarkets-com\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Europe Ophthalmic Drug Delivery System Market to Grow at 6.4% Through 2031 &#8211; ResearchAndMarkets.com","datePublished":"2022-08-29T17:01:49+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/europe-ophthalmic-drug-delivery-system-market-to-grow-at-6-4-through-2031-researchandmarkets-com\/"},"wordCount":517,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/europe-ophthalmic-drug-delivery-system-market-to-grow-at-6-4-through-2031-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220829005595\/en\/1555663\/21\/logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/europe-ophthalmic-drug-delivery-system-market-to-grow-at-6-4-through-2031-researchandmarkets-com\/","url":"https:\/\/pharma-trend.com\/en\/europe-ophthalmic-drug-delivery-system-market-to-grow-at-6-4-through-2031-researchandmarkets-com\/","name":"Europe Ophthalmic Drug Delivery System Market to Grow at 6.4% Through 2031 - ResearchAndMarkets.com - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/europe-ophthalmic-drug-delivery-system-market-to-grow-at-6-4-through-2031-researchandmarkets-com\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/europe-ophthalmic-drug-delivery-system-market-to-grow-at-6-4-through-2031-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220829005595\/en\/1555663\/21\/logo.jpg","datePublished":"2022-08-29T17:01:49+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/europe-ophthalmic-drug-delivery-system-market-to-grow-at-6-4-through-2031-researchandmarkets-com\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/europe-ophthalmic-drug-delivery-system-market-to-grow-at-6-4-through-2031-researchandmarkets-com\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/europe-ophthalmic-drug-delivery-system-market-to-grow-at-6-4-through-2031-researchandmarkets-com\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220829005595\/en\/1555663\/21\/logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220829005595\/en\/1555663\/21\/logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/europe-ophthalmic-drug-delivery-system-market-to-grow-at-6-4-through-2031-researchandmarkets-com\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Europe Ophthalmic Drug Delivery System Market to Grow at 6.4% Through 2031 &#8211; ResearchAndMarkets.com"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/47769","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=47769"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/47769\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=47769"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=47769"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=47769"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}